DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Lawitz E, Poordad F, Brainard D et al.
Sofosbuvir in combination with PEG-IFN and ribavirin for 12 weeks provides high SVR rates in HCV infected genotype 2 or 3 treatment-experienced patients with and without compensated cirrhosis: results from the Lonestar-2 study.

Hepatology 2013;
58: LB-4

Download Bibliographical Data

Search in: